Area of Research: Therapeutic Targeting
2019 Grant Recipients
-
Isaac Klein, MD, PhD,
Dana Farber Cancer Institute
Ann and Sol Schreiber Mentored Investigator AwardTranscriptional Regulatory Landscape of High Grade Serous Ovarian Cancer
-
Xiaowen Hu, PhD,
University of Pennsylvania
Liz Tilberis Early Career AwardTargeting Chromatin Remodeling Complex to Treat Ovarian Cancer
-
Kate Lawrenson, PhD,
Cedars-Sinai Medical Center
Liz Tilberis Early Career AwardElucidating the Role of SOX17 in HGSOC
-
Ronald Buckanovich, MD, PhD,
Magee-Womens Research Institute
Collaborative Research Development GrantTargeting Tumor Desmoplasia to Enhance Immunotherapy
2017 Grant Recipients
-
Nabanita Chatterjee, PhD,
MD Anderson Cancer Center
Ann and Sol Schreiber Mentored Investigator AwardOvarian Cancer Disrupts Circadian Cortisol Rhythms
-
Jagmohan Hooda, PhD,
University of Pennsylvania
Ann and Sol Schreiber Mentored Investigator AwardLoss of H2Bub1 Rewires Glutamine Metabolism During Progression of HGSOC
-
Dongyu Jia, PhD,
Cedars-Sinai Medical Center
Ann and Sol Schreiber Mentored Investigator AwardCOL11A Is A Highly Specific Therapeutic Target in Cancer-Activated Stroma
-
Ronen Marmorstein, PhD,
University of Pennsylvania
Collaborative Research Development GrantChromatin Regulatory Mechanisms in Ovarian Cancer
2016 Grant Recipients
-
Fan Zhao, PhD,
Stanford University
Ann and Sol Schreiber Mentored Investigator AwardOvarian Cancer Antigen Discovery by Single t-cell Analysis and pHLA Library
2015 Grant Recipients
-
Alfredo Perales-Puchalt, MD,
The Wistar Institute
Ann and Sol Schreiber Mentored Investigator AwardTargeting FSH Receptor with Chimeric Antigen Receptor in Ovarian Cancer
2014 Grant Recipients
-
Rachel Grisham, MD,
Memorial Sloan Kettering Cancer Center
Liz Tilberis Early Career AwardDetermining the Molecular Drivers of Low-Grade Serous Ovarian Cancer
-
Selvendiran Karuppaiyah, PhD,
Ohio State University
Liz Tilberis Early Career AwardNew Type of Experimental Drug for Ovarian Cancer
-
Ilana Chefetz, PhD,
University of Michigan
Ann and Sol Schreiber Mentored Investigator AwardA Role for ALDH in the Regulation of Necroptosis in Ovarian Cancer Area of research: Therapeutic Targeting
-
Kyung Hee Noh, PhD,
MD Anderson Cancer Center
Ann and Sol Schreiber Mentored Investigator AwardTargeting Adaptive Changes to anti-VEGF Therapy in Ovarian Cancer
-
Shailja Pathania, PhD,
Dana Farber Cancer Institute
Ann and Sol Schreiber Mentored Investigator AwardNovel Therapeutic Targets for High-Grade Serous Ovarian Carcinoma
2013 Grant Recipients
-
Maria Barbolina, PhD,
University of Illinois - Chicago
Liz Tilberis Early Career AwardChemokine-Dependent Control of Survival in Ovarian Carcinoma
-
Stephanie Gaillard, MD, PhD,
Duke Cancer Institute
Liz Tilberis Early Career AwardEvaluating ERRalpha as a Novel Therapeutic Target in Ovarian Cancer
-
Teng Ma, MD, PhD,
University of Michigan - Ann Arbor
Ann and Sol Schreiber Mentored Investigator AwardThe Analysis of NEDD8-activating Enzyme Inhibitor MLN4924 on Ovarian Cancer
-
Xin Huang, PhD,
Magee-Womens Research Institute
Liz Tilberis Early Career AwardNoval Strategy of Metabolic Targeting Ovarian Cancer: Focusing on the Tumor Hypoxia Pathway
-
Mythreye Karthikeyan, PhD,
University of South Carolina
Liz Tilberis Early Career AwardInvestigating the TGFß Superfamily as Therapeutic Targets in Ovarian Cancer
-
Joyce Liu, MD, MPH,
Dana Farber Cancer Institute
Liz Tilberis Early Career AwardInvestigating ErbB3 as a Novel Therapeutic Target in Ovarian Cancer
-
Yin Wang, PhD,
Mayo Clinic Jacksonville
Ann and Sol Schreiber Mentored Investigator AwardProtein Kinase C iota is a Novel Therapeutic Target for Ovarian Cancer Treatment
2012 Grant Recipients
-
Bin Guan, PhD,
Johns Hopkins University School of Medicine
Ann and Sol Schreiber Mentored Investigator AwardFunctional Characterization of the Tumor Suppressor ARID1A in Ovarian Cancer
-
Karen Cowden Dahl, PhD,
Indiana University
Liz Tilberis Early Career AwardInvestigation of ARID3B Splicing as a Novel Therapeutic Target for Ovarian Cancer
-
Hanqing Liu, PhD,
Fox Chase Cancer Center
Ann and Sol Schreiber Mentored Investigator AwardTargeting Signaling Networks via RNAi to Improve Therapy for Ovarian Cancer
-
W. Ruprecht Wiedemeyer, PhD,
Cedars-Sinai Medical Center
Liz Tilberis Early Career AwardOvarian Cancer Evolution After Targeted Therapy
2011 Grant Recipients
-
Santo Nicosia, MD,
University South Florida
Collaborative Research Development GrantOvarian Cancer: A Theme Based Approach Toward Identification of Novel Diagnostic and Therapeutic Targets
-
Sherry Wu, PhD,
MD Anderson Cancer Center
Ann and Sol Schreiber Mentored Investigator AwardNovel Approach to Destroy the Blood Supply that Feeds Ovarian Cancer Tumors
-
Selvendiran Karuppaiyah, PhD,
Ohio State University
Liz Tilberis Early Career AwardSafe, Targeted, Antitumor Therapeutics (STAT3 Inhibitors) for Ovarian Cancer
2008 Grant Recipients
-
Takayo Ota, MD, PhD,
Mayo Clinic Rochester
Ann and Sol Schreiber Mentored Investigator AwardCharacterizing the Genetic Alterations of Aggressive Ovarian Cancer
-
Thuy-Vy Do, PhD,
Fox Chase Cancer Center
Ann and Sol Schreiber Mentored Investigator AwardUnderstanding How Ovarian Cancer Spreads
2007 Grant Recipients
-
Martin Matthew Matzuk, MD, PhD,
Baylor College of Medicine
Collaborative Research Development GrantMicroRNA’s as Diagnostic and Therapeutic Targets in Ovarian Cancer
-
Mitchell Cheung, PhD,
Fox Chase Cancer Center
Ann and Sol Schreiber Mentored Investigator AwardTesting New Therapeutic Agents to Treat Ovarian Cancer
2005 Grant Recipients
-
Anil K. Sood, MD,
MD Anderson Cancer Center
Collaborative Research Development GrantNovel siRNA Based Therapeutic Approaches for Ovarian Carcinoma
-
Andrew K. Godwin, PhD,
Fox Chase Cancer Center
Collaborative Research Development GrantTherapeutic Targeting of the Tumor Microenvironment in Ovarian Cancer
2004 Grant Recipients
-
Ernst Lengyel, MD, PhD,
University of Chicago
Liz Tilberis Early Career AwardRole and Regulation of Hepatocyte Growth Factor and c-Met in Ovarian Cancer
2001 Grant Recipients
-
Kimberly Kalli, PhD,
Mayo Clinic
Liz Tilberis Early Career AwardFunctional Significance of Insulin Receptors in Epithelial Ovarian Cancer: Therapeutic Implications